Patent Applications published on Jun 29, 2023 - page 4

#901
US20230201174A1
Human necessities

COMBINATION OF FINERENONE AND A SGLT2 INHIBITOR FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR AND/OR RENAL DISEASES

#902 ✅ Patent 11,896,585 granted on 2024-02-13
US20230201175A1
Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

#903 ✅ Patent 11,793,795 granted on 2023-10-24
US20230201176A1
Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

#904
US20230201177A1
Human necessities

Topical Roflumilast Aerosol Foams

#905 ✅ Patent 11,883,386 granted on 2024-01-30
US20230201178A1
Human necessities

Prolyl hydroxylase inhibitors and methods of use

#906
US20230201179A1
Human necessities

AGENT FOR TREATING CONTRAST-INDUCED ACUTE KIDNEY INJURY

#907 ✅ Patent 11,813,255 granted on 2023-11-14
US20230201180A1
Human necessities

Methods of treating Fabry patients having renal impairment

#908 ✅ Patent 12,239,638 granted on 2025-03-04
US20230201181A1
Human necessities

Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

#909
US20230201182A1
Human necessities

CHEMICAL SYNTHESIS OF CLOPIDOGREL ACTIVE METABOLITES AND DISULFIDE CONJUGATE PRODRUGS

#910
US20230201183A1
Human necessities

METHODS TO SYNERGISTICALLY ENHANCE MULTIPLE CELLULAR PROTEOSTASIS PATHWAYS TO TREAT NEURODEGENERATION AND STORAGE DISEASES

#911
US20230201184A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SCHIZOPHRENIA

#912
US20230201185A1
Human necessities

TREATMENT OF TYPE 2 DIABETES OR OBESITY OR OVERWEIGHT WITH 2-[(4-{6-[(4-CYANO-2-FLUOROBENZYL)OXY]PYRIDIN-2-YL}PIPERIDIN-1-YL)METHYL]-1-[(2S)-OXETAN-2-YLMETHYL]-1H-BENZIMIDAZOLE-6-CARBOXYLIC ACID OR A PHARMACEUTICALLY SALT THEREOF

#913 ✅ Patent 11,998,539 granted on 2024-06-04
US20230201186A1
Human necessities

Substituted aminoquinolones as DGKalpha inhibitors for immune activation

#914
US20230201187A1
Human necessities

USE OF NAD+ PRECURSORS, STING INHIBITORS, AND FXR AGONISTS FOR INHIBITING SARS-COV-2 (COVID-19)-INDUCED CYTOKINE RELEASE

#915
US20230201188A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING LEUKEMIA

#916 ✅ Patent 12,005,059 granted on 2024-06-11
US20230201189A1
Human necessities

Nemonoxacin malate active pharmaceutical ingredient with low combination impurities, and a preparation method thereof

#917
US20230201190A1
Human necessities

USE OF MULTIFUNCTIONAL LIGANDS FOR TREATING THE RESPIRATORY DISTRESS AND CYTOKINE STORM SYNDROMES ASSOCIATED WITH CORONAVIRUS VIRAL INFECTIONS

#918
US20230201191A1
Human necessities

PLATINUM COMPOUNDS THAT INHIBIT CONSTITUTIVE STAT3 SIGNALING AND INDUCE CELL CYCLE ARREST AND APOPTOSIS OF MALIGNANT CELLS

#919
US20230201192A1
Human necessities

METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER

#920
US20230201193A1
Human necessities

COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS

#921
US20230201194A1
Human necessities

COMBINATION COMPOSITIONS FOR IMMUNOTHERAPY

#922 ✅ Patent 12,295,954 granted on 2025-05-13
US20230201195A1
Human necessities

Methods of treating fibrosis

#923
US20230201196A1
Human necessities

METHODS OF TREATING FIBROSIS

#924 ✅ Patent 12,109,211 granted on 2024-10-08
US20230201197A1
Human necessities

Hydralazine compositions and methods

#925
US20230201198A1
Human necessities

METHODS OF TREATING ABNORMAL CELL GROWTH

#926
US20230201199A1
Human necessities

THERAPEUTIC DRUG FOR DYSKINESIA

#927
US20230201200A1
Human necessities

Methods for Treating Huntington’s Disease

#928
US20230201201A1
Human necessities

COMPOSITION FOR USE IN THE TREATMENT OF APOL1-ASSOCIATED DISEASE

#929
US20230201202A1
Human necessities

COMPOSITIONS AND METHODS FOR SENSITIZING ACUTE MYELOID LEUKEMIAS TO CHEMOTHERAPY

#930
US20230201203A1
Human necessities

METHODS OF TREATMENT USING ANTIFOLATES AND PHARMACEUTICAL FORMULATIONS COMPRISING ANTIFOLATES

#931
US20230201204A1
Human necessities

Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates

#932 ✅ Patent 12,268,691 granted on 2025-04-08
US20230201205A1
Human necessities

Treating extrapyramidal syndrome using trapidil

#933
US20230201206A1
Human necessities

METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA

#934
US20230201207A1
Human necessities

COMBINATION CANCER THERAPY USING N2-QUINOLINE OR ISOQUINOLINE SUBSTITUTED PURINE DERIVATIVES

#935
US20230201208A1
Human necessities

COMPOSITION AND METHODS FOR TREATING RESPIRATORY DISEASES

#936
US20230201209A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING ANTIVIRAL AGENT AND ANTIDEPRESSANT AS ACTIVE INGREDIENTS

#937
US20230201210A1
Human necessities

COMBINATIONS OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE

#938 ✅ Patent 11,911,393 granted on 2024-02-27
US20230201211A1
Human necessities

Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof

#939
US20230201212A1
Human necessities

INHIBITORS OF EZH2 AND METHODS OF USE THEREOF

#940
US20230201213A1
Human necessities

USE OF EZH2 INHIBITORS FOR TREATING CANCER

#941
US20230201214A1
Human necessities

LPXC INHIBITOR, FORMULATIONS, AND USES THEREOF

#942
US20230201215A1
Human necessities

DRUG COMBINATIONS FOR INHIBITING INFECTIVITY OF INFLUENZA AND CORONA VIRUSES

#943
US20230201216A1
Human necessities

AZELASTINE AS ANTIVIRAL TREATMENT

#944
US20230201217A1
Human necessities

18-MC FOR TREATMENT OF SUBSTANCE USE DISORDERS

#945
US20230201218A1
Human necessities

BETA-LACTAMASE INHIBITORS AND USES THEREOF

#946 ✅ Patent 11,865,119 granted on 2024-01-09
US20230201219A1
Human necessities

Methods of treating agitation and other dementia-associated behavioral symptoms

#947
US20230201220A1
Human necessities

DIETARY SUPPLEMENT

#948
US20230201221A1
Human necessities

USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

#949
US20230201222A1
Human necessities

ALLEVIATION OF LIVER INJURY BY ACTIVATING THE SIGNALING PATHWAY MEDIATED BY FARNESOID X RECEPTOR

#950
US20230201223A1
Human necessities

Methods of Treating Residual Lesions of Vascular Anomalies

#951
US20230201224A1
Human necessities

19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF

#952
US20230201225A1
Human necessities

METHODS OF TREATING MULTIPLE SCLEROSIS

#953
US20230201226A1
Human necessities

COMBINATION THERAPY FOR REDUCING DRUG-INDUCED NEPHROTOXICITY, DYSLIPIDEMIA AND HYPERGLYCEMIA

#954
US20230201227A1
Human necessities

COMBINATION THERAPY FOR CANCER TREATMENT

#955
US20230201228A1
Human necessities

IMMUNOMODULATORY OLIGOSACCHARIDES

#956 ✅ Patent 11,957,698 granted on 2024-04-16
US20230201229A1
Human necessities

Synergistic combination of thermolysin and an antibacterial agent to reduce or eliminate bacterial biofilms from surfaces

#957 ✅ Patent 11,865,129 granted on 2024-01-09
US20230201230A1
Human necessities

Application of anemoside B4 in preparation of a drug for treatment or prevention of psoriasis

#958
US20230201231A1
Human necessities

ADMINISTRATION OF AN ANTI-ACTIVIN-A COMPOUND TO A SUBJECT

#959
US20230201232A1
Human necessities

COMPOSITION FOR AMELIORATION, PREVENTION OR TREATMENT OF HAIR LOSS, COMPRISING CATECHIN 7-O-beta-D-APIOFURANOSIDE AS ACTIVE INGREDIENT

#960
US20230201233A1
Human necessities

USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, AND NICOTINAMIDE MONONUCLEOTIDE, REDUCED NICOTINYL COMPOUNDS, AND NICOTINOYL COMPOUND DERIVATIVES IN INFANT FORMULA FOR HEALTHY DEVELOPMENT

#961
US20230201234A1
Human necessities

FAST DISPERSIBLE PHARMACEUTICAL COMPOSITION COMPRISING CAPECITABINE

#962
US20230201235A1
Human necessities

INHIBITION OF NIDOVIRUSES THAT ENCODE NSP15

#963
US20230201236A1
Human necessities

SPIROCYCLIC NUCLEOSIDE ANALOGUES FOR THE TREATMENT OF HEPATITIS E

#964
US20230201237A1
Human necessities

RESPONSE-GUIDED HCV THERAPY

#965
US20230201238A1
Human necessities

THERAPEUTIC AGENT FOR AN RNA VIRUS INFECTION COMPRISING A COMBINATION OF A PYRAZINE DERIVATIVE AND A THIOPURINE DERIVATIVE

#966
US20230201239A1
Human necessities

ALKYNYL NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E

#967
US20230201240A1
Human necessities

TREATMENT OF ADVANCED METASTATIC CANCER

#968 ✅ Patent 11,844,759 granted on 2023-12-19
US20230201241A1
Human necessities

Compositions comprising circular polyribonucleotides and uses thereof

#969
US20230201242A1
Human necessities

RIG-I AGONISTS AND METHODS USING SAME

#970
US20230201243A1
Human necessities

MODULATORS OF FOXP3 EXPRESSION

#971
US20230201244A1
Human necessities

COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING MICROBIAL INFECTIONS

#972
US20230201245A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING VIRUS INFECTION

#973
US20230201246A1
Human necessities

METAL COMPOSITIONS AND METHODS OF USE THEREOF

#974 ✅ Patent 11,744,849 granted on 2023-09-05
US20230201247A1
Human necessities

Hydroxypropyl beta-cyclodextrin compositions and methods

#975
US20230201248A1
Human necessities

COMPOSITIONS AND METHODS OF USE THEREOF

#976
US20230201249A1
Human necessities

COMPOSITIONS INCORPORATING SULFATED POLYSACCHARIDES FOR INHIBITING SARS-COV-2

#977 ✅ Patent 11,938,146 granted on 2024-03-26
US20230201250A1
Human necessities

Treatment for coronavirus infection and associated cytokine toxicity

#978
US20230201251A1
Human necessities

METHODS FOR USING BIOADHESIVE AND STERIC INTERACTIONS OF COPOLYMERS WITH AT LEAST TWO MOIETIES TO MINIMIZE ADVERSE EFFECTS MEDIATED BY EXTERNAL INFLUENCES ON CELL, TISSUE, ORGAN SYSTEM, AND ORGANISM BIOLOGY

#979
US20230201252A1
Human necessities

HYDRATION COMPOSITIONS

#980
US20230201253A1
Human necessities

SYSTEMS AND METHODS FOR ADMINISTERING HYDRATION COMPOSITIONS

#981
US20230201254A1
Human necessities

DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS

#982 ✅ Patent 12,161,666 granted on 2024-12-10
US20230201255A1
Human necessities

Composition comprising cinnamaldehyde and zinc to improve swallowing

#983
US20230201256A1
Human necessities

CALCINEURIN INHIBITOR TO IMPROVE CD3+CELL SURVIVAL TO THEREBY FACILITATE ENGRAFTMENT OF DONOR CD34+ CELLS IN A RECIPIENT

#984
US20230201257A1
Human necessities

DE-NOVO DESIGNED TRANSMEMBRANE POLYPEPTIDES AND THEIR USES IN CELLULAR IMMUNOTHERAPY

#985
US20230201258A1
Human necessities

Polyspecific Binding Molecules and their use in Cell Therapy

#986
US20230201259A1
Human necessities

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

#987
US20230201260A1
Human necessities

METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY

#988
US20230201261A1
Human necessities

CD19-TARGETED CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF

#989
US20230201262A1
Human necessities

MYELOMA-SPECIFIC IMMUNITY REQUIRES THE DIFFERENTIATION OF STEM-LIKE MEMORY T CELLS IN THE BONE MARROW

#990
US20230201263A1
Human necessities

PRETREATMENT DRUG FOR T CELL INFUSION THERAPY FOR IMMUNE-CHECKPOINT INHIBITOR-RESISTANT TUMOR

#991
US20230201264A1
Human necessities

IMMUNE CELLS DEFECTIVE FOR SUV39H1

#992
US20230201265A1
Human necessities

COMPOSITIONS COMPRISING NON-VIABLE FECAL MICROBIOTA AND METHODS OF USE THEREOF

#993 ✅ Patent 12,310,990 granted on 2025-05-27
US20230201266A1
Human necessities

Method for treating arthritis by using stem cell preparation and method for preparing stem cell preparation

#994
US20230201267A1
Human necessities

RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTOR DUAL CELL AGGREGATES AND METHODS OF USE THEREOF

#995
US20230201268A1
Human necessities

TREATMENT OF CANCER BY ADMINISTRATION OF NEURONS AND DERIVATIVES THEREOF

#996
US20230201269A1
Human necessities

TREATMENT OF FRONTOTEMPORAL DEMENTIA USING FIBROBLASTS AND PRODUCTS THEREOF

#997
US20230201270A1
Human necessities

FIBROBLAST THERAPY FOR PREVENTION AND REVERSION OF ANEURYSMS

#998
US20230201271A1
Human necessities

FECAL MATTER FOR TREATMENT OF CACHEXIA

#999
US20230201272A1
Human necessities

CELL-BASED THERAPIES AND USES THEREOF

#1000
US20230201273A1
Human necessities

NOVEL DEINOCOCCUS RADIODURANS STRAIN, EXOPOLYSACCHARIDE DERIVED THEREFROM, AND COMPOSITION COMPRISING THE SAME

#1001
US20230201274A1
Human necessities

SHELF- STABLE AMMONIA OXIDIZING MICROORGANISM PREPARATIONS

#1002
US20230201275A1
Human necessities

RECOMBINANT BACTERIA PRODUCING CHEMICALS INHIBITORY TO SALMONELLA INVASION

#1003
US20230201276A1
Human necessities

METHOD OF TREATING OR PREVENTING AN INFECTION

#1004
US20230201277A1
Human necessities

COMPOSITION FOR TREATING RESPIRATORY DISEASES OR INFLAMMATORY DISEASES CAUSED BY FINE DUST STIMULATION, CONTAINING LACTIC ACID BACTERIA

#1005 ✅ Patent 11,801,274 granted on 2023-10-31
US20230201278A1
Human necessities

Method for alleviating atopic dermatitis

#1006
US20230201279A1
Human necessities

USE OF LACTOBACILLUS PARACASEI GM-080 FOR MODULATING IMMUNE FUNCTION

#1007 ✅ Patent 11,969,450 granted on 2024-04-30
US20230201280A1
Human necessities

Methods for improving gastrointestinal barrier function and inhibiting growth of enteric pathogenic bacteria

#1008
US20230201281A1
Human necessities

VAGINAL MICROBIOTA COMPOSITIONS

#1009
US20230201282A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING LIPID-RELATED METABOLIC DISEASES, COMPRISING LACTOBACILLUS PLANTARUM ATG-K2 OR ATG-K6

#1010
US20230201283A1
Human necessities

RECOMBINANT VACCINIA VIRUS

#1011
US20230201284A1
Human necessities

Uses and Formulations of Cannabinoids

#1012
US20230201285A1
Human necessities

GRANULAR COMPOSITION PROVIDING WATER DISPERSIBLE CANNABINOIDS AND METHODS OF MAKING THE SAME

#1013 ✅ Patent 11,793,848 granted on 2023-10-24
US20230201286A1
Human necessities

High yield extraction method for and products of plants

#1014 ✅ Patent 11,801,279 granted on 2023-10-31
US20230201287A1
Human necessities

High yield extraction method for and products of plants

#1015
US20230201288A1
Human necessities

COMPOSITION FOR RECOVERY FROM FATIGUE

#1016 ✅ Patent 12,329,796 granted on 2025-06-17
US20230201289A1
Human necessities

ANTI-OBESITY COMPOSITION

#1017
US20230201290A1
Human necessities

TGF-BETA INHIBITION, AGENTS AND COMPOSITION THEREFOR

#1018 ✅ Patent 12,128,082 granted on 2024-10-29
US20230201291A1
Human necessities

Method for extracting flavone aglycones in , extract obtained thereby and anti-inflammatory pharmaceutical composition

#1019
US20230201292A1
Human necessities

HERBAL FORMULATION FOR THE PREVENTION AND MANAGEMENT OF TYPE-2 DIABETES MELLITUS AND ASSOCIATED MICROVASCULAR COMPLICATIONS

#1020
US20230201293A1
Human necessities

APPLICATION OF A TRADITIONAL CHINESE MEDICINE COMPOSITION AND FORMULATION THEREOF IN THE PREPARATION OF MEDICAMENTS FOR PREVENTING AND/OR TREATING NOVEL CORONAVIRUS PNEUMONIA

#1021
US20230201294A1
Human necessities

AQUEOUS EXTRACTION PROCESS OF PLANTS, METHOD THEREOF, AND PRODUCT BY PROCESS

#1022 ✅ Patent 12,042,523 granted on 2024-07-23
US20230201295A1
Human necessities

Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof

#1023 ✅ Patent 12,357,670 granted on 2025-07-15
US20230201296A1
Human necessities

TOPICAL CREAM-BASED COSMETIC AND WOUND HEALING FORMULATIONS AND METHODS OF USE

#1024
US20230201297A1
Human necessities

COMPOSITION COMPRISING SAFRANAL AND PROBIOTICS

#1025
US20230201298A1
Human necessities

LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES

#1026
US20230201299A1
Human necessities

METHODS FOR THE PREVENTION AND TREATMENT OF BURN INJURIES AND SECONDARY COMPLICATIONS

#1027
US20230201300A1
Human necessities

STABLE INTRANASAL FORMULATIONS OF CARBETOCIN

#1028
US20230201301A1
Human necessities

TREM-1 INHIBITOR FOR USE IN THE TREATMENT OF A SUBJECT SUFFERING FROM A CORONAVIRUS INFECTION

#1029
US20230201302A1
Human necessities

ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS

#1030
US20230201303A1
Human necessities

METHODS FOR TREATING PANCREATIC CANCER AND OTHER SOLID TUMORS

#1031
US20230201304A1
Human necessities

METHOD FOR INDUCING GLIAL CELLS TRANSDIFFERENTIATION INTO FUNCTIONAL NEURONS, AND APPLICATION THEREOF

#1032
US20230201305A9
Human necessities

IMMUNE CHECKPOINT INHIBITOR COMBINATIONS

#1033
US20230201306A1
Human necessities

Fibroblast growth factor 21 (FGF21) gene therapy for central nervous system disorders

#1034
US20230201307A1
Human necessities

LIQUID FORMULATION OF GM-CSF FOR INHALATION

#1035
US20230201308A1
Human necessities

TREATMENT OF CORONAVIRUS INFECTION WITH INTERFERON LAMBDA

#1036
US20230201309A1
Human necessities

COMPOSITIONS FOR THE TREATMENT OF A RESPIRATORY CONDITION

#1037
US20230201310A1
Human necessities

STAT3 PHOSPHORYLATION INHIBITOR, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASE AND CORONAVIRUS INFECTION

#1038
US20230201311A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH)

#1039
US20230201312A1
Human necessities

PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION

#1040
US20230201313A1
Human necessities

METHODS OF TREATING LEFT VENTRICLE HYPERTROPHY

#1041
US20230201314A1
Human necessities

USE OF ADVANCED PLATELET-RICH FIBRIN IN PREPARING MEDICAMENT FOR TREATMENT OF DIABETIC FOOT ULCER

#1042
US20230201315A1
Human necessities

TNAP LOCALLY ADMINISTERED FOR PROMOTING PERIODONTAL HEALTH

#1043
US20230201316A1
Human necessities

ATP-HYDROLYZING ENZYME USEFUL FOR TREATING DYSBIOSIS

#1044
US20230201317A1
Human necessities

PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES

#1045
US20230201318A1
Human necessities

METHODS FOR TREATING HYPOPHOSPHATASIA IN CHILDREN AND ADOLESCENTS

#1046
US20230201319A1
Human necessities

ADAMTS13 COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING COMPLICATIONS OF CORONAVIRUS DISEASE

#1047
US20230201320A1
Human necessities

MIMOTOPES OF ALPHA-SYNUCLEIN AND VACCINES THEREOF FOR THE TREATMENT OF SYNUCLEINOPATHY

#1048
US20230201321A1
Human necessities

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS

#1049 ✅ Patent 12,263,210 granted on 2025-04-01
US20230201322A1
Human necessities

Immunogenic compounds for cancer therapy

#1050
US20230201323A1
Human necessities

VACCINE FORMULATIONS

#1051
US20230201324A1
Human necessities

Compositions and Methods for Treating Cocaine, Nicotine, and Methamphetamine Dependence

#1052 ✅ Patent 12,128,094 granted on 2024-10-29
US20230201325A1
Human necessities

Immunogenic compositions comprising OMVs, an acellular pertussis antigen, a tetanus toxoid and a diphtheria toxoid

#1053
US20230201326A1
Human necessities

Immunogenic Compositions and Vaccines in the Treatment and Prevention of Infections

#1054
US20230201327A1
Human necessities

RSV VACCINE BEARING ONE OR MORE P GENE MUTATIONS

#1055
US20230201328A1
Human necessities

LARGE AND SMALL T ANTIGENS OF MERKEL CELL POLYOMAVIRUS, NUCLEIC ACID CONSTRUCTS AND VACCINES MADE THEREFROM, AND METHODS OF USING SAME

#1056
US20230201329A1
Human necessities

INFLUENZA VACCINE

#1057
US20230201330A1
Human necessities

Virus-like particles containing RSV antigen protein and vaccines using the same

#1058
US20230201331A1
Human necessities

Compositions and Methods for Inducing an Immune Response

#1059 ✅ Patent 12,194,090 granted on 2025-01-14
US20230201332A1
Human necessities

Tetanus vaccine platform for embedding COVID-19 vaccine

#1060
US20230201333A1
Human necessities

EFFICIENT VACCINE

#1061
US20230201334A1
Human necessities

MODIFIED HUMAN CYTOMEGALOVIRUS PROTEINS

#1062
US20230201335A1
Human necessities

Antigen Presenting Polypeptide Complexes and Methods of Use Thereof

#1063
US20230201336A1
Human necessities

INFLUENZA VIRUS-LIKE PARTICLES (VLPS)

#1064
US20230201337A1
Human necessities

VACCINE COMPOSITIONS COMPRISING ENDOGENOUS GAG POLYPEPTIDES

#1065 ✅ Patent 12,280,107 granted on 2025-04-22
US20230201338A1
Human necessities

Pneumococcal conjugate vaccine formulations

#1066
US20230201339A1
Human necessities

USE OF THIAZOLE AMIDE COMPOUNDS FOR MODULATING HUMAN IMMUNE RESPONSE

#1067
US20230201340A1
Human necessities

ADJUVANTS FOR SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS (SARS-COV) VACCINES

#1068
US20230201341A1
Human necessities

TLR3 AND TLR9 AGONISTS AS VACCINE ADJUVANTS FOR ANTI-CANCER DNA VACCINES

#1069
US20230201342A1
Human necessities

USE OF LENVATINIB PLUS ANTI-PD-1 MONOCLONAL ANTIBODY IN PREPARATION OF ANTI-HEPATOMA DRUG

#1070
US20230201343A1
Human necessities

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES

#1071
US20230201344A1
Human necessities

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY

#1072
US20230201345A1
Human necessities

ANTI-PD-L1 ANTIBODIES

#1073
US20230201346A1
Human necessities

BINDING MOLECULES SPECIFIC FOR IL-21 AND USES THEREOF

#1074 ✅ Patent 11,857,626 granted on 2024-01-02
US20230201347A1
Human necessities

Method of enhancing mental function and acuity by delivering biochemical scaffolds

#1075
US20230201348A1
Human necessities

NITRIC OXIDE HYDROGEL FOR PROMOTING TUMOR VASCULAR NORMALIZATION AND RADIOSENSITIZATION AND PREPARATION METHOD THEREOF

#1076
US20230201349A1
Human necessities

ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF

#1077
US20230201350A1
Human necessities

ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF

#1078
US20230201351A1
Human necessities

ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF

#1079 ✅ Patent 12,194,102 granted on 2025-01-14
US20230201352A1
Human necessities

Compositions for enhancing bioavailability of pharmaceuticals, supplements and ingested substances

#1080
US20230201353A1
Human necessities

SUSTAINED RELEASE DELIVERY SYSTEMS COMPRISING TRACELESS LINKERS

#1081
US20230201354A1
Human necessities

CARBON NANOTUBES AND COMPLEXES THEREOF FOR TREATING AND DETECTING OCULAR TUMORS

#1082 ✅ Patent 11,879,001 granted on 2024-01-23
US20230201355A1
Human necessities

Conjugate comprising an IL-2 moiety

#1083
US20230201357A1
Human necessities

D-DIMER-SPECIFIC APTAMERS AND METHODS OF USE IN DIAGNOSTICS, THERAPEUTIC AND THERANOSTIC PURPOSES

#1084
US20230201358A1
Human necessities

LINKER COMPOUNDS

#1085
US20230201359A1
Human necessities

MONOCYTE-SPECIFIC APTAMERS AND USES THEREOF FOR DELIVERING THERAPEUTIC AGENTS TO HEART

#1086
US20230201360A1
Human necessities

Composition and Kit for colonization in gut of external probiotics through bioorthogonal click chemistry

#1087
US20230201361A1
Human necessities

TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES

#1088 ✅ Patent 11,872,287 granted on 2024-01-16
US20230201362A1
Human necessities

Compositions and methods of treating muscle atrophy and myotonic dystrophy

#1089 ✅ Patent 12,263,224 granted on 2025-04-01
US20230201363A1
Human necessities

Compositions and methods of treating muscle atrophy and myotonic dystrophy

#1090
US20230201364A1
Human necessities

ANTIBODY CONJUGATES AND MANUFACTURE THEREOF

#1091
US20230201365A1
Human necessities

MODIFIED CD20 ANTIBODIES AND USES THEREOF

#1092
US20230201366A1
Human necessities

ANTI-PSMA CONJUGATES

#1093 ✅ Patent 11,964,026 granted on 2024-04-23
US20230201367A1
Human necessities

Layer-by-layer nanoparticles for cytokine therapy in cancer treatment

#1094 ✅ Patent 12,076,417 granted on 2024-09-03
US20230201368A1
Human necessities

Plasma-derived nanoparticles

#1095
US20230201369A1
Human necessities

NALOXONE NANOPARTICLE COMPOSITIONS AND METHODS THEREOF

#1096
US20230201370A1
Human necessities

EXOSOMES COMPRISING THERAPEUTIC POLYPEPTIDES

#1097
US20230201371A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING OCULAR DISORDERS

#1098
US20230201372A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SLC26A4-ASSOCIATED HEARING LOSS

#1099
US20230201373A1
Human necessities

CRISPR-MEDIATED GENOME EDITING WITH VECTORS

#1100
US20230201374A1
Human necessities

GENE THERAPY AND TARGETED DELIVERY OF CONJUGATED COMPOUNDS

#1101
US20230201375A1
Human necessities

TARGETED GENOMIC INTEGRATION TO RESTORE NEUROFIBROMIN CODING SEQUENCE IN NEUROFIBROMATOSIS TYPE 1 (NF1)

#1102
US20230201376A1
Human necessities

NEUROGENIC TISSUE NANOTRANSFECTION IN THE MANAGEMENT OF CUTANEOUS DIABETIC POLYNEUROPATHY

#1103
US20230201377A1
Human necessities

COMPOSITION AND METHODS OF GENOME EDITING OF B-CELLS

#1104
US20230201378A1
Human necessities

APPLICATION OF MITOXANTRONE PREPARATION IN PREPARATION OF DRUG FOR DIAGNOSING AND TREATING DISEASE RELATED TO THYROIDECTOMY

#1105
US20230201379A1
Human necessities

FUNCTIONALIZED NANOPARTICLES AND METHODS OF MAKING AND USING SAME

#1106
US20230201380A1
Human necessities

NON-INVASIVE AND LONGITUDINAL MONITORING OF MICROGLIAL ACTIVATION IN RAT BRAIN WITH SUPERMAGNETIC NANOPARTICLE ENHANCED MR IMAGING

#1107 ✅ Patent 12,239,721 granted on 2025-03-04
US20230201381A1
Human necessities

Polydopamine decorated tobacco mosaic theranostic virus nanoparticles

#1108
US20230201382A1
Human necessities

RADIOLIGANDS FOR MYELIN

#1109
US20230201383A1
Human necessities

PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER RADIOTHERAPY AND IMAGING

#1110
US20230201384A1
Human necessities

FGFR3-TARGETED RADIOIMMUNOCONJUGATES AND USES THEREOF

#1111
US20230201385A1
Human necessities

BIOMEDICAL IMAGING OF BACTERIA AND VIRUSES

#1112
US20230201386A1
Human necessities

PRODUCING RADIOPHARMACEUTICAL COLD KITS WITHOUT LYOPHILIZATION

#1113 ✅ Patent 11,752,225 granted on 2023-09-12
US20230201387A1
Human necessities

Systems and methods for producing sterile injection devices

#1114
US20230201388A1
Human necessities

UVC IRRADIATION DISINFECTION SYSTEMS AND METHODS

#1115
US20230201389A1
Human necessities

SYSTEM FOR IRRADIATING OBJECTS WITH ULTRAVIOLET LIGHT

#1116
US20230201390A1
Human necessities

Sterilisation of Endoscopes

#1117
US20230201391A1
Human necessities

STERILISATION APPARATUS FOR PRODUCING PLASMA AND HYDROXYL RADICALS

#1118
US20230201392A1
Human necessities

AIR FLOW TREATMENT SYSTEM AND METHOD FOR VENTILATION SYSTEMS

#1119
US20230201393A1
Human necessities

DISINFECTION SYSTEMS AND METHODS USING POLYMER COMPOSITIONS THAT FORM CHLORINE DIOXIDE GAS

#1120 ✅ Patent 12,156,953 granted on 2024-12-03
US20230201394A1
Human necessities

Sanitization system and method

#1121
US20230201395A1
Human necessities

SYSTEM AND METHOD FOR SANITIZING AT LEAST ONE SURFACE

#1122
US20230201396A1
Human necessities

ROBOT AND CONTROL METHOD THEREOF

#1123
US20230201397A1
Human necessities

HEALTH SYSTEM OF FARM AND CONSTRUCTION EQUIPMENT

#1124
US20230201398A1
Human necessities

SMART OIL SPRAY ADAPTER

#1125
US20230201399A1
Human necessities

TRAY SANITIZATION SYSTEMS AND METHODS

#1126 ✅ Patent 11,819,588 granted on 2023-11-21
US20230201400A1
Human necessities

System and method for ultra-close proximity irradiation of rotating biomass

#1127
US20230201401A1
Human necessities

FILTER INSERT AND DEVICE FOR STERILIZATION AND/OR DISINFECTION THEREOF

#1128 ✅ Patent 11,786,624 granted on 2023-10-17
US20230201402A1
Human necessities

Aroma component volatilization device, and method for manufacturing aroma component volatilization device

#1129
US20230201403A1
Human necessities

Emitter and System for Discharge of a Decontaminating Liquid-Gas Stream

#1130
US20230201404A1
Human necessities

SYSTEM, APPARATUS, AND METHOD FOR REMOVING PATHOGENS FROM A DENTAL OPERATORY

#1131
US20230201405A1
Human necessities

ANTIVIRAL FILTER MEDIUM, AND AIR FILTER UNIT AND AIR CONDITIONER INCLUDING SAME

#1132
US20230201406A1
Human necessities

LASER SYSTEMS, METHODS AND DEVICES OF PROCESSING AND SANITIZING AIR FLOW AND SURFACES

#1133
US20230201407A1
Human necessities

CORONA STERILIZATION MODULE

#1134
US20230201408A1
Human necessities

Electronic Breathing Mask with UVC Air Purification System and Peripherals

#1135 ✅ Patent 11,759,541 granted on 2023-09-19
US20230201409A1
Human necessities

Air treatment unit

#1136 ✅ Patent 12,370,283 granted on 2025-07-29
US20230201410A1
Human necessities

VEHICLE STERILIZING APPARATUS AND COCKPIT MODULE HAVING THE SAME

#1137
US20230201411A1
Human necessities

PHOTOCATALYTIC AIR TREATMENT

#1138
US20230201412A1
Human necessities

PROACTIVE AIR/SURFACE DECONTAMINATION SYSTEM AND DEVICES FOR BUILDING HVAC DUCTS

#1139
US20230201413A1
Human necessities

COMPOSITIONS COMPRISING DRAGLINE SPIDER SILK

#1140
US20230201414A1
Human necessities

DEVICES COMPRISING HYALURONIC ACID AND SILK FIBROIN

#1141
US20230201415A1
Human necessities

WOUND CARE COMPOSITIONS AND METHODS OF PREPARATION THEREOF

#1142
US20230201416A1
Human necessities

IMPLANT MAGNESIUM ALLOY, BONE FIXTURE, METHOD OF MANUFACTURING IMPLANT MAGNESIUM ALLOY, AND METHOD OF MANUFACTURING BONE FIXTURE DEVICE

#1143
US20230201417A1
Human necessities

Pharmaceutical composition for eardrum repair and use thereof

#1144
US20230201418A1
Human necessities

SOFT TISSUE AUGMENTATION USING INJECTABLE, NEUTRAL PH SOLUBLE COLLAGEN-GLYCOSAMINOGLYCAN COMPOSITIONS

#1145
US20230201419A1
Human necessities

PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME

#1146
US20230201420A1
Human necessities

Engineered Three-Dimensional Skin Tissues, Arrays Thereof, and Methods of Making the Same

#1147
US20230201421A1
Human necessities

TISSUE MATRICES INCORPORATING MULTIPLE TISSUE TYPES

#1148
US20230201422A1
Human necessities

Formulation comprising a phosphocalcic cement and a physical and/or covalent hydrogel of polysaccharides, printable and having ductile mechanical properties for bone regeneration/bone repair

#1149 ✅ Patent 12,042,576 granted on 2024-07-23
US20230201423A1
Human necessities

Cell sheet construct for neurovascular reconstruction and manufacture thereof

#1150
US20230201424A1
Human necessities

TEMPERATURE-SENSITIVE GEL MATERIAL COMBINATION, PREPARATION METHOD THEREFOR AND USE THEREOF

#1151
US20230201425A1
Human necessities

BIOMATERIALS FOR ENHANCED IMPLANT-HOST INTEGRATION

#1152
US20230201426A1
Human necessities

GEL COMPOSITION AND PRODUCTION METHOD THEREFOR, AND THREE-DIMENSIONAL TISSUE BODY AND PRODUCTION METHOD THEREFOR

#1153
US20230201427A1
Human necessities

METHOD FOR PREPARING STRUCTURED HYDROGEL AND METHOD FOR PREPARING HYDROGEL HEART VALVE

#1154 ✅ Patent 12,280,181 granted on 2025-04-22
US20230201428A1
Human necessities

Intravascular devices

#1155
US20230201429A1
Human necessities

COATING WITH STRONG ADHESION FOR MEDICAL MAGNESIUM ALLOYS AND PREPARATION THEREOF

#1156
US20230201430A1
Human necessities

HYDRAULIC PUMPING SYSTEM FOR EXPRESSION OF BRAST MILK

#1157
US20230201431A1
Human necessities

Electrical Isolation Devices, Methods and Systems

#1158
US20230201432A1
Human necessities

Determining a Volume of a Container for Dialysis Treatment

#1159 ✅ Patent 12,161,787 granted on 2024-12-10
US20230201433A1
Human necessities

Method of heat sanitization of a haemodialysis water circuit using a calculated dose

#1160
US20230201434A1
Human necessities

Peritoneal Dialysis System with Constant Volume Disposable Pump

#1161
US20230201435A1
Human necessities

PERITONEAL DIALYSIS USING PRESSURIZED CYLINDER

#1162
US20230201436A1
Human necessities

PERITONEAL DIALYSIS SYSTEM HAVING CARBON DIOXIDE INJECTION TO INHIBIT/REMOVE CALCIUM CARBONATE

#1163
US20230201437A1
Human necessities

GAS TREATMENT DELIVERY SYSTEMS AND METHODS

#1164
US20230201438A1
Human necessities

COMPOUNDS, SYSTEMS, AND TECHNIQUES FOR REMOVAL OF PERIPHERAL AMYLOID BETA PEPTIDE WITH ALBUMIN BINDING COMPETITORS

#1165 ✅ Patent 12,053,567 granted on 2024-08-06
US20230201439A1
Human necessities

Method and device for removal of circulating cell free DNA

#1166
US20230201440A1
Human necessities

SYSTEM AND METHOD FOR GENE AND/OR CELLULAR THERAPY

#1167
US20230201441A1
Human necessities

PERITONEAL DIALYSIS SYSTEM HAVING AIR-AIDED PUMPING SEQUENCES

#1168 ✅ Patent 12,042,596 granted on 2024-07-23
US20230201442A1
Human necessities

Mobile negative pressure wound therapy device configured for start-up test

#1169
US20230201443A1
Human necessities

PULSE WIDTH MODULATION (PWM) OPERATED VACUUM RELIEF VALVE IN CONJUNCTION WITH AN ANTI-VACUUM SURGE (AVS) MODULE

#1170 ✅ Patent 12,280,201 granted on 2025-04-22
US20230201444A1
Human necessities

Otitis media treatment instrument

#1171
US20230201445A1
Human necessities

APPARATUSES AND METHODS FOR NEGATIVE PRESSURE WOUND THERAPY

#1172
US20230201446A1
Human necessities

PERISTALTIC PUMPS WITH SELECTIVE ACTIVATION OF MULTIPLE FLUID LINES AND FLUID MANAGEMENT SYSTEMS INCLUDING THE SAME

#1173
US20230201447A1
Human necessities

Sterilization Arrangement for Drug Delivery Device

#1174 ✅ Patent 11,878,140 granted on 2024-01-23
US20230201448A1
Human necessities

Sterilization arrangement for drug delivery device

#1175
US20230201449A1
Human necessities

A PACKAGE ASSEMBLY

#1176 ✅ Patent 12,138,417 granted on 2024-11-12
US20230201450A1
Human necessities

Workpiece carrier for components of drug delivery devices

#1177
US20230201451A1
Human necessities

TECHNIQUES FOR MANAGING FLUID DELIVERY DEVICE OPERATING MODE TRANSITIONS

#1178
US20230201452A1
Human necessities

INFUSION PUMPS AND METHODS WITH SHAPE MEMORY WIRE DRIVEN SYRINGE MECHANISM

#1179 ✅ Patent 11,779,697 granted on 2023-10-10
US20230201453A1
Human necessities

Device for subcutaneous delivery of fluid medicament

#1180
US20230201454A1
Human necessities

IMPLANTABLE INTRATHECAL DRUG DELIVERY SYSTEM FOR CHRONIC PAIN CONTROL

#1181
US20230201455A1
Human necessities

IMPLANTABLE DRUG STORAGE DEVICES FOR DRUG DELIVERY

#1182
US20230201456A1
Human necessities

INFUSION BOX OF INFUSION APPARATUS, INFUSION APPARATUS, AND INFUSION PUMP

#1183
US20230201457A1
Human necessities

MASS TRANSPORT INSIDE MAMMALS

#1184 ✅ Patent 12,364,813 granted on 2025-07-22
US20230201458A1
Human necessities

PRESSURE INDICATOR FOR MEDICAMENT DELIVERY DEVICE

#1185 ✅ Patent 11,918,784 granted on 2024-03-05
US20230201459A1
Human necessities

Liquid medicine injection device

#1186
US20230201460A1
Human necessities

MULTIPLE USE COMPUTERIZED INJECTOR

#1187
US20230201461A1
Human necessities

SYSTEMS AND METHODS FOR REMOTELY PROCESSING DATA COLLECTED BY A DRUG DELIVERY DEVICE

#1188 ✅ Patent 11,793,938 granted on 2023-10-24
US20230201462A1
Human necessities

Devices for injecting medicaments and methods of use

#1189
US20230201463A1
Human necessities

Medicament Delivery System

#1190
US20230201464A1
Human necessities

PHARMACEUTICAL CONTAINER AND LIQUID COMPOSITION

#1191
US20230201465A1
Human necessities

RESIN SYRINGE, PREFILLED SYRINGE, AND METHOD FOR PRODUCING RESIN SYRINGE

#1192
US20230201466A1
Human necessities

Sensor System

#1193
US20230201467A1
Human necessities

A METHOD OF INSERTING A LUBRICANT FREE STOPPER INTO A LUBRICANT FREE BARREL OR A LUBRICANT FREE CARTRIDGE TUBE AND A SYSTEM FOR ASSEMBLING SAME

#1194
US20230201468A1
Human necessities

VERSATILE SYRINGE PLATFORM

#1195 ✅ Patent 11,918,790 granted on 2024-03-05
US20230201469A1
Human necessities

Drug injection device

#1196 ✅ Patent 11,964,128 granted on 2024-04-23
US20230201470A1
Human necessities

Liquid medicine injection device

#1197
US20230201471A1
Human necessities

Safety Device for Shielding an Injection Needle of a Medical Container, and an Injection Device Including This Safety Device

#1198
US20230201472A1
Human necessities

Safety Device for Shielding an Injection Needle of a Medical Container, and an Injection Device Including This Safety Device

#1199
US20230201473A1
Human necessities

Safety Device for Shielding an Injection Needle of a Medical Container, and an Injection Device Including This Safety Device

#1200
US20230201474A1
Human necessities

Safety Device for Shielding an Injection Needle of a Medical Container, and an Injection Device Including This Safety Device